Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting ischemic cardiac dysfunction through gene transfer.

Takashi Matsui1, Anthony Rosenzweig

  • 1Program in Cardiovascular Gene Therapy, Massachusetts General Hospital, 114 16th Street, Room 2600, Charlestown, MA 02129, USA. arosenzweig@partners.org

Current Atherosclerosis Reports
|April 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endogenous oxytocin-linked heart-rate synchrony and social connection during live sports spectatorship.

Translational psychiatry·2026
Same author

Ex vivo heart perfusion induces time dependent inflammatory activation in human donor hearts.

NPJ cardiovascular health·2026
Same author

Long noncoding RNA SALTe1, microvascular ageing, and cardiac dysfunction.

European heart journal·2026
Same author

2-Mercaptoethanol/DMSO Workflow Enables Highly Reproducible Quantitative Proteomics.

Journal of proteome research·2026
Same author

Corrigendum to "Ferroptosis in heart failure" [Journal of Molecular and Cellular Cardiology, Volume 173 (2022) Pages 141-153].

Journal of molecular and cellular cardiology·2026
Same author

A Streamlined Synthesis of Adenosine Vinylsulfonamide Probes for Aminoacyl-AMP Mimicry in NRPS.

Chembiochem : a European journal of chemical biology·2026

Apoptotic cardiomyocyte death contributes to ischemic cardiac injury from atherosclerosis. Targeting survival pathways offers potential therapeutic strategies for ischemic heart disease.

Area of Science:

  • Cardiovascular Biology
  • Cellular Biology
  • Pathophysiology

Background:

  • Atherosclerosis is a leading cause of global morbidity and mortality.
  • Ischemic cardiac injury is a significant complication of atherosclerosis.
  • Apoptotic cardiomyocyte death's role in ischemic injury is not fully understood.

Purpose of the Study:

  • To review general mechanisms of apoptosis.
  • To present evidence on the functional contribution of apoptotic cell death in ischemic injury.
  • To identify potential therapeutic targets for ischemic heart disease.

Main Methods:

  • Review of general apoptosis mechanisms.
  • Analysis of interventional studies on ischemic injury.
  • Discussion of gene transfer as a research and therapeutic tool.

Related Experiment Videos

Main Results:

  • Apoptotic cell death plays a significant role in the pathogenesis of ischemic injury.
  • Signaling pathways regulating cardiomyocyte survival and function converge.
  • These converging pathways are attractive therapeutic targets.

Conclusions:

  • Apoptotic cardiomyocyte death is functionally important in ischemic heart disease.
  • Targeting converging survival pathways holds therapeutic promise.
  • Gene transfer is a valuable tool for target validation and therapy.